Pharmacist Impact on DKA Outcomes in the Emergency Department at Tucson Medical Center
dc.contributor.advisor | Mosher, Daniel | |
dc.contributor.advisor | Robertson, Richard | |
dc.contributor.author | Leluan, Amanda | |
dc.contributor.author | Sammani, Nora | |
dc.contributor.author | Staskauskas, Max | |
dc.contributor.author | Yu, Cammy | |
dc.date.accessioned | 2024-01-08T17:02:21Z | |
dc.date.available | 2024-01-08T17:02:21Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | http://hdl.handle.net/10150/670632 | |
dc.description | Class of 2023 Abstract and Poster | en_US |
dc.description.abstract | Specific Aims: To determine outcomes in patients when a pharmacist is involved in the initial care of DKA in the emergency department versus when a pharmacist is not involved in initial management. Methods: Patients included in this study were 18 years or older with a primary admission diagnosis of DKA , received at least 2L of resuscitation fluid. and were admitted through the TMC emergency department. Data were collected retrospectively through the electronic health record (Epic). Results are presented using appropriate statistical calculations for continuous and categorical variables. This study was a hospital quality improvement project. Results were quantified and presented but comparative statistics between groups were not performed. Results: Baseline characteristics were similar between the pharmacist intervention and non- pharmacist intervention groups. There was no difference in mortality between groups. The pharmacist intervention group had a mean time to DKA resolution of 31.0 ± 21.6 hours versus 40.6 ± 30.0 hours in the non-pharmacist intervention group. Hospital length of stay was shorter in the pharmacist intervention group than the non-pharmacist intervention group (89.4 ± 30.0 hours versus 114.9 ± 57.3 hours). PCCU length of stay (42.6 ± 31.3 versus 46.9 ± 38.4) and ICU length of stay (0.74 ± 3.0 versus 4.8 ± 15.9) were both lower in the pharmacist intervention group. Conclusions: Pharmacist intervention in the emergency department at Tucson Medical Center improves time to DKA resolution and hospital length of stay. Further studies are required to establish statistical significance and achieve larger sample sizes with fewer uncontrolled variables. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | The University of Arizona. | en_US |
dc.rights | Copyright © is held by the author. | en_US |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | |
dc.subject | Emergency department | en_US |
dc.subject | pharmacist involvement | en_US |
dc.subject | Diabetic ketoacidosis (DKA) | en_US |
dc.subject | hospital quality improvement project | en_US |
dc.title | Pharmacist Impact on DKA Outcomes in the Emergency Department at Tucson Medical Center | en_US |
dc.type | Poster | |
dc.type | text | |
dc.contributor.department | College of Pharmacy, The University of Arizona | en_US |
dc.description.collectioninformation | This item is part of the Pharmacy Student Research Projects collection, made available by the College of Pharmacy and the University Libraries at the University of Arizona. For more information about items in this collection, please contact Jennifer Martin, Librarian and Clinical Instructor, Pharmacy Practice and Science, jenmartin@email.arizona.edu. | en_US |
refterms.dateFOA | 2024-01-08T17:02:34Z |